Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Six-Month, Multi-Center, Open-Label Study to Assess the Safety and Efficacy of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions

NCT00491894 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT00491894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00491894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Six-Month, Multi-Center, Open-Label Study to Assess the Safety and Efficacy of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions
Lead sponsor
Shionogi
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2007
Completion date
June 30, 2008
Enrollment
137 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, mental retardation, neurological conditions, sialorrhea